Janus Henderson Group
AEON icon

Janus Henderson Group’s AEON Biopharma AEON Stock Holding History

Janus Henderson Group’s Portfolio AEON Stock Details AEON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,113
Closed -$2.25M – 2685
2022
Q4 		$2.25M Sell
3,113
-1,919
-38% -$1.37M ﹤0.01% 1065
2022
Q3 		$3.57M Buy
5,032
+3,629
+259% +$2.57M ﹤0.01% 1088
2022
Q2 		$991K Hold
1,403
– – ﹤0.01% 1332
2022
Q1 		$989K Buy
+1,403
New +$984K ﹤0.01% 1519

Other funds holding AEON

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
SIM
Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
GCWM
Graham Capital Wealth Management Washington D.c., District of Columbia $113M AUM 11.26% 1-Year Est. Return

Janus Henderson Group's AEON Position: Q1 2023 in Review

Janus Henderson Group sold out of AEON Biopharma (AEON) in Q1 2023, closing a stake of 3,113 shares — an estimated $2.25M sold.

Janus Henderson Group first reported a position in AEON in Q1 2022 and held it in 4 quarters. The position peaked at $3.57M in Q3 2022. 21 funds tracked by Wall St. Rank hold AEON as of Q1 2023.

  • Janus Henderson Group reported no remaining AEON Biopharma position as of Q1 2023 after selling out during the quarter.
  • Janus Henderson Group sold 3,113 AEON Biopharma shares in Q1 2023, an estimated $2.25M.
  • Janus Henderson Group first reported a position in AEON Biopharma in Q1 2022 and held it in 4 quarters.
  • Janus Henderson Group's AEON Biopharma position peaked at $3.57M in Q3 2022.
  • 21 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2023.

Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.